期刊文献+

猪乳铁蛋白肽的分子改良及改良肽的生物学活性研究 被引量:1

Molecular Improvement of Porcine Lactoferricin and Biological Activity of the Modified Peptides
下载PDF
导出
摘要 本研究采用化学合成的方法获得了猪源乳铁蛋白肽LFP-20及其改良肽,旨在通过研究该抗菌肽一级结构与抗菌活性的关系,获得抗菌活性更高的改良肽。微量肉汤稀释法测定的最小抑菌浓度(MIC)及溶血性分析结果表明,猪乳铁蛋白肽LFP-20及其改良肽LF2A、LF-1和LF-3对大肠杆菌、猪霍乱沙门氏菌、鼠伤寒沙门氏菌、金黄色葡萄球菌及表皮葡萄球菌均具有抗菌活性;LFP-20对5种试验菌株的MIC为64~128 μg/mL,改良肽LF-1和LF-3的MIC降低了2~4倍;改良肽LF2A对5种试验菌株的抗菌活性没有提高,但溶血性降低;改良肽LF-1的抗菌活性有所提高,但在4、32、64、128和256 μg/mL时的溶血性也显著提高(P〈0.05)。WST-1和LDH法检测4种抗菌肽对人外周血单核细胞(PBMC)增殖的影响及细胞毒性结果表明,LF2A、LF-1和LF-3对PBMC增殖的影响具有剂量依赖性;与LFP-20相比,25~200 μg/mL的LF-1显著提高了PBMC的增殖(P〈0.05),但在400 μg/mL浓度下却抑制了PBMC的增殖(P〈0.05);200和400 μg/mL LF-1使得PBMC的乳酸脱氢酶(LDH)释放百分率显著提高(P〈0.05),在25~50 μg/mL浓度下却对LDH释放具有降低作用(P〈0.05)。对细胞膜去极化作用研究结果表明,4 μg/mL的改良肽LF-3对大肠杆菌细胞膜的去极化作用明显增强,而抗菌活性较低的LFP-20和LF2A对细菌细胞膜的去极化作用低于LF-3。由此可知,改良肽LF-3的抗菌活性比猪乳铁蛋白肽LFP-20提高了2~4倍,且溶血作用和细胞毒性均没有显著增强;LF-3可通过对细胞膜的去极化作用破坏大肠杆菌细胞膜电势梯度平衡,推测对细胞膜的破坏作用是其发挥抗菌作用的途径之一。 In this study,porcine lactoferricin LFP-20 and its analogs were prepared by chemical synthesis with an aim to understand structure-function relationships of these peptides and thereby to obtain improved analogs.The minimum inhibitory concentration(MIC) measured by broth microdilution method and hemolytic analysis showed that the 20-residue porcine lactoferricin(LFP-20) and its analogs LF2A,LF-1,and LF-3 displayed the antimicrobial activity against Escherichia coli,Salmonella choleraesuis,Salmonella typhimurium,Staphylococcus aureus and Staphylococcus epidermidis.The minimum inhibitory concentrations of LFP-20 ranged from 64 to 128 μg/mL,and LF-1 and LF-3 were 2 to 4 times more effective than LFP-20.The studies demonstrated that the analog LF2A,replacing the 2-and 17-Cys of LFP-20 with Ala,did not show increased activities against bacteria,but exhibited decreased hemolytic activity.The analog LF-1,replacing the 9-and 18-Ile of LFP-20 with Trp,showed improved antimicrobial activity.But the hemolytic activity of LF-1 was also increased at 4,32,64,128,and 256 μg/mL(P0.05).The cytotoxic potential of LFP-20 analogs was quantified by colorimetric WST-1 and LDH assays in peripheral blood mononuclear cell(PBMC).LF2A,LF-1 and LF-3 increased cell proliferation and viability in a dose dependent fashion.Compared with LFP-20,25 to 200 μg/mL LF-1 improved significantly cell proliferation(P0.05),while 400 μg/mL LF-1 decreased cell proliferation(P0.05).Both 200 and 400 μg/mL LF-1 induced an increase in lactate dehydrogenase(LDH) release from PBMC(P0.05) whereas 25 to 50 μg/mL decreased the LDH release(P0.05).Moreover,LF-3 exhibited obviously enhanced potential to depolarize the cytoplasmic membranes at relatively low concentrations(4 μg/mL).In contrast,LFP-20 and LF2A had more modest antibacterial activities,and a weaker ability to depolarize the cytoplasmic membrane.In conclusion,the antimicrobial activity of LF-3 is found to be 2 to 4 folds higher than that of LFP-20,which dose not couple with increased heomolysis and cytotoxicity to PBMCs.Moreover,LF-3 can disrupt the membrane potential by depolarizing the bacterial membrane,which is proposed to be one of the mechanisms of action of LF-3.
出处 《动物营养学报》 CAS CSCD 北大核心 2011年第2期241-249,共9页 CHINESE JOURNAL OF ANIMAL NUTRITION
基金 国家高技术研究发展计划(2007AA100602) 高等学校全国优秀博士学位论文作者专项资金资助项目(2007B6)资助
关键词 乳铁蛋白肽 抗菌活性 溶血性 细胞毒性 porcine lactoferricin antimicrobial activity hemolytic activity cytotoxicity
  • 相关文献

参考文献21

  • 1GIFFORD J L,HUNTER H N,VOGEL H J.Lactoferricin:a lactoferrin-derived peptide with antimicrobial,antiviral,antitumor and immunological properties[J].Cellular and Molecular Life Sciences,2005,62:2588-2598.
  • 2STRφM M B,REKDAL O,SVENDSEN J S,et al.The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin[J].Journal of Peptide Science,2002,8 (1):36-43.
  • 3HWANG P M,ZHOU N,SHAN X,et al.Three-dimensional solution structure of lactoferricin B,an antimicrobial peptide derived from bovine lactoferrin[J].Biochemistry,1998,42(3):388-392.
  • 4VOGEL H J,SCHIBLI D J,JING W,et al.Towards a structure-function analysis of bovine lactoferricin and related tryptophan-and arginine-containing peptides[J].Biochemistry,2002,80:49-63.
  • 5HUNTER H N,DEMCOE A R,JENSSEN H,et al.Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent[J].Antimicrob Agents Chemother,2005,49(8):3387-3395.
  • 6STRφM M B,REKDAL O,SVENDSE J S.Antibacterial activity of 15-residue lactoferricin derivatives[J].Journal of Peptide Research,2000,56:265-274.
  • 7STRφM M B,HAUG B E,REKD M Q,et al.Important structural features of 15-residue lactoferricin derivatives and methods for improvements of antimicrobial activity[J].Biochemistry,2002,80:65-74.
  • 8CHEN H L,YEN C C,LU C Y,et al.Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli,Staphylococcus aureus,and Candida albicans[J].Journal of Agricultural and Food Chemistry,2006,54:3277-3282.
  • 9WU M,HANCOCK R E W.Improved derivatives of bactenecin,a cyclic dodecameric antimicrobial cationic peptide[J].Antimicrobial Agents and Chemotherapy,1999,43(5):1274-1276.
  • 10WIEGAND I,HILPERT K,HANCOCK R E W.Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances[J].Nature Protocols,2008,3:163-175.

二级参考文献28

共引文献13

同被引文献67

  • 1Fabbretti A, Gualerzi C O, Brandi L. How to cope with the quest for new antibiotics. Febs Lett, 2011,585(11): 1673-1681.
  • 2Reddy K V R, Yedery R D, Aranha C. Antimicrobial peptides: Premises and promises. Int J Antimicrob Ag, 2004, 24(6): 536-547.
  • 3Sato H, Feix J B. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic a-helical antimicrobial peptides. BBA-Biomembranes, 2006, 1758(9): 1245-1256.
  • 4Keymanesh K, Soltani S, Sardari S. Application of antimicrobial peptides in agriculture and food industry. World J Mierob Biot, 2009, 25(6): 933-944.
  • 5Brogden N K, Brogden K A. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?. Int J Antimicrob Ag, 2011, 38(3): 217-225.
  • 6Giuliani A, Rinaldi A. Beyond natural antimierobial peptides: Multimeric peptides and other peptidomimetic approaches. Cell Mol Life Sci, 2011, 68(13): 2255-2266.
  • 7Rotem S, Mor A. Antimicrobial peptide mimics for improved therapeutic properties. BBA-Biomembranes, 2009, 1788(8): 1582- 1592.
  • 8John A R. Protein epitope mimetics as anti-infectives. Curr OpinChem Biol, 2011, 15(3): 379-386.
  • 9Findlay B, Zhanel G G, Schweizer F. Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimiocrob Agents Ch, 2010, 54(10): 4049-4058.
  • 10Lienkamp K, Tew G N. Synthetic mimics of antimicrobial peptides—A versatile ring-opening metathesis polymerization based platform for the synthesis of selective antibacterial and cell-penetrating polymers. Chem Eur J, 2009, 15 (44): 11784- 11800.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部